Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026)

Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Nurix Therapeutics 2.64 Bn 2.19 Bn - 15.59 Mn

Historic Data

Download Data
DateValue
May 31, 2026 15.59 Mn
Feb 28, 2026 14.61 Mn
Nov 30, 2025 13.65 Mn
Aug 31, 2025 13.16 Mn
May 31, 2025 14.28 Mn
Feb 28, 2025 11.65 Mn
Nov 30, 2024 10.72 Mn
Aug 31, 2024 11.72 Mn
May 31, 2024 11.71 Mn
Feb 29, 2024 11.80 Mn
Nov 30, 2023 10.78 Mn
Aug 31, 2023 10.62 Mn
May 31, 2023 11.68 Mn
Feb 28, 2023 9.82 Mn
Nov 30, 2022 9.37 Mn
Aug 31, 2022 9.75 Mn
May 31, 2022 9.65 Mn
Feb 28, 2022 9.23 Mn
Nov 30, 2021 8.82 Mn
Aug 31, 2021 8.34 Mn